1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.

CURA.TO
Curaleaf Holdings, Inc.CA flagToronto Stock Exchange
13.39
CAD
+0.07
- -
3.12BMarket Cap
Curaleaf Holdings, Inc.
CURA.TO
(Toronto Stock Exchange)

Recent

price

13.39

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
0.18
0.58
1.43
3.37
5.13
5.38
5.58
5.4
4.99
5.02
Revenue per Share
-0.12
-0.59
-0.31
-0.03
-0.43
-0.44
-0.31
-0.48
-1.56
-1.16
-0.96
-1.08
-0.6
Basic EPS, GAAP
-0.09
-0.6
-0.28
-0.17
-0.59
-0.78
-0.61
-0.88
-0.37
0.02
0.27
0.29
0.21
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.13
0.36
-0.03
0.94
4.48
3.63
8.42
8.26
-3.63
-4.73
-5.49
-6.25
-5.94
Book Value per Share
0.19
0.52
0.09
0.43
2.54
0.96
0.72
0.79
-1.85
-2.6
-2.92
-3.17
-2.77
Tangible Book Value per Share
- -
- -
- -
108
132
154
186
233
237
241
247
254
255
Basic Weighted Avg Shares
- -
- -
- -
19
77
221
627
1,196
1,275
1,347
1,334
1,268
1,282
Sales/Revenue/Turnover
- -
- -
- -
-33.89
-37.22
-12.54
11.56
13.88
5.1
3.18
1.85
2.01
1.43
Operating Margin (%)
- -
- -
- -
4
9
37
80
133
166
212
248
216
216
Depreciation Expense
- -
- -
- -
-3
-56
-67
-57
-111
-370
-281
-238
-273
-154
Net Income, GAAP
- -
- -
- -
- -
- -
- -
284.29
315.35
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
-14.59
-73.28
-30.42
-9.12
-9.31
-29.02
-20.88
-17.85
-21.56
-12.04
Profit Margin (%)
- -
- -
- -
32
289
43
198
627
156
-75
46
154
165
Working Capital
- -
- -
- -
10
82
169
555
732
852
819
724
760
760
LT Debt
- -
- -
- -
105
436
403
1,381
1,799
1,401
1,171
993
840
909
Total Equity
- -
- -
- -
- -
- -
- -
-10.06
-15.11
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
-12.76
-12.26
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-219.75
- -
- -
-16.3
-11.67
-5.38
-6.38
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
74
67
73
LT Borrowings
500
513
525
LT Finance Leases
249
247
235
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
255
257
260
Market Capitalization
2,078
1,876
1,652

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
440
449
462
Cash, Cash Equivalents & STI
93
89
106
Accounts Receivable, Net
67
74
71
Inventories
229
225
241
Total Current Liabilities
299
294
296
Payables & Accruals
179
204
199
ST Debt
74
67
73
Deferred Revenue
1
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28,991.83%
-7.77%
-15.41%
Free Cash Flow
1,857.32%
232.66%
10.38%
Net Income, GAAP
446.85%
60.52%
14.78%
Sales/Revenue/Turnover
- -
19.44%
-4.96%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
339
342
331
331
1,334
2025
307
315
320
323
1,268
2026
324
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.19
-0.2
-0.16
- -
-0.96
2025
-0.25
-0.26
-0.22
- -
-1.08
2026
0.27
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
ManifestSeven Holdings Corporation (MNFSF)
Ortin Global Ltd (ORTINGLOBE.BO)
Pharmaxis Ltd (PXS.AX)
Octavia Wellness Inc. (OCTVV)
Vitalibis, Inc. (VCBDQ)
Khiron Life Sciences Corp. (KHRWF)
Business
Curaleaf Holdings, Inc. (Ticker: CURA.TO) operates as a leading international cannabis company focused on the cultivation, processing, and retail sale of cannabis products. The company offers a diverse portfolio of branded consumer products including flower, pre-rolls, and concentrates under its flagship Select brand; vaporizer cartridges under the Select Elite and Select Essentials lines; edibles such as gummies, chocolates, and beverages under Grassroots and Curaleaf brands; and tinctures, topicals, and other wellness products; alongside wholesale services to third-party dispensaries and cultivation operations supporting medical and adult-use markets. Curaleaf serves medical patients and recreational consumers primarily in the United States through its network of Curaleaf retail dispensaries and Quickleaf delivery services, with additional operations in Europe via subsidiaries like PRIMA Cannabis and Emmac Life Sciences. Founded in 2010 and headquartered in Stamford, Connecticut, the company maintains a vertically integrated model across 23 U.S. states and select international markets. In recent developments within the last two years, Curaleaf expanded its European footprint through the 2024 acquisition of a majority stake in UK-based PRIMA Cannabis, strengthening its medical cannabis distribution; launched new product lines including low-dose edibles and beverage formats in key U.S. markets amid regulatory approvals; formed strategic partnerships with pharmaceutical distributors for international expansion; and benefited from uplisted trading capabilities on major exchanges following favorable U.S. federal rescheduling progress in 2024-2025.